In a hepatocellular carcinoma model, the triple-treatment caused increased CD8+ T cell infiltration, less regulatory T cells and increased immunological memory compared to after co-treatment with radiotherapy and anti-PD-L1 (21). The gene discussed is CD8A; the disease is hepatocellular carcinoma.